Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2021

View Archived Issues

Shire Human Genetic Therapies describes IDS gene therapy

New influenza A virus vaccine synthesized at the University of Gdansk

Pentadefenin hydrogel developed for treating vaginitis

GS-441524 is an effective antiviral against African swine fever virus in vitro

Results of phase I trial of CRAd-S-pk7 oncolytic adenovirus delivered by neural stem cells in glioma

Possible target LGALS3BP binds to SARS-CoV-2 spike glycoprotein

Sinovent patents CDK7/cyclin H inhibitors

New protein O-GlcNAcase inhibitors discovered at Janssen Pharmaceutica

Phase Ib extension data for belapectin plus Keytruda in melanoma and head and neck cancer

FDA places clinical hold on phase I/II study of SIG-001 in hemophilia A

Eli Lilly initiates phase I study of LY-3819469

Enrollment ongoing first-in-human study of PBI-200

ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults

Ranitidine bismuth citrate shows potency for treating SARS-CoV-2 infection

Rare coding variant increases risk of Y chromosome loss, diabetes

Dosing begins in phase I study in China of IBI-323 for advanced malignant tumors

FDA clears initiation of phase II trial of pyrilutamide in androgenetic alopecia

Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer

NTLA-2001 decreases serum TTR protein concentrations through targeted knockout of TTR

Ampligen to be studied in phase IIa human challenge trial as intranasal antiviral therapy

Octenidine shows potential for treating multidrug-resistant Candida infection

Preliminary phase II data with COVID-19 vaccine candidate GRAd-COV2 support progression

Inotrem gains clearance in France and Belgium to advance nangibotide for COVID-19

Enterome begins dosing in phase I/II study of EO-2463 in indolent NHL

Amniotics to advance PulmoStem into clinic next year

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...